Cite
¹⁸FDG-PET/CT for prognostic stratification of patients with multiple myeloma relapse after stem cell transplantation
MLA
Lapa, Constantin, et al. ¹⁸FDG-PET/CT for Prognostic Stratification of Patients with Multiple Myeloma Relapse after Stem Cell Transplantation. Jan. 2014. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.unidue...bib..0e972886cf8003213bbb1bd9276635ae&authtype=sso&custid=ns315887.
APA
Lapa, C., Lückerath, K., Malzahn, U., Samnick, S., Einsele, H., Buck, A. K., Herrmann, K., & Knop, S. (2014). ¹⁸FDG-PET/CT for prognostic stratification of patients with multiple myeloma relapse after stem cell transplantation.
Chicago
Lapa, Constantin, Katharina Lückerath, Uwe Malzahn, Samuel Samnick, Herrmann Einsele, Andreas K. Buck, Ken Herrmann, and Stefan Knop. 2014. “¹⁸FDG-PET/CT for Prognostic Stratification of Patients with Multiple Myeloma Relapse after Stem Cell Transplantation,” January. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.unidue...bib..0e972886cf8003213bbb1bd9276635ae&authtype=sso&custid=ns315887.